Literature DB >> 20399952

Randomized trial of buccal versus vaginal misoprostol for induction of second trimester abortion.

Sacheen Carr Ellis1, Nathalie Kapp, Olivera Vragpvoc, Lynn Borgata.   

Abstract

BACKGROUND: We evaluated the efficacy and acceptability of repeat doses of buccal misoprostol compared to vaginal misoprostol for second trimester pregnancy termination by induction. STUDY
DESIGN: Women requesting termination of a pregnancy between 18 and 22 weeks gestation were approached for participation. All women received 400 mcg misoprostol vaginally on admission. Participants were randomized to receive subsequent doses of 200 mcg misoprostol every 6 h either buccally or vaginally. All participants completed an acceptability survey.
RESULTS: Sixty-four women participated. The mean gestational age was 19.7 weeks. The median time to abortion in the buccal group was 15 h, which was not significantly different (p=0.44) from the vaginal-only group of 12 h. Most women in both groups preferred their allocated administrative route.
CONCLUSION: Repeat doses of buccal misoprostol are as effective as vaginal misoprostol in inducing abortions in the midtrimester and are highly acceptable to most women. It is reasonable to offer both options to women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399952     DOI: 10.1016/j.contraception.2009.12.018

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

1.  Buccal versus vaginal misoprostol administration for the induction of first and second trimester abortions.

Authors:  Geetika Garg; Navneet Takkar; Alka Sehgal
Journal:  J Obstet Gynaecol India       Date:  2014-10-31

2.  Vaginal versus sublingual misoprostol for labor induction at term and post term: a randomized prospective study.

Authors:  Sedigheh Ayati; Fatemeh Vahidroodsari; Farnoosh Farshidi; Masoud Shahabian; Monavar Afzal Aghaee
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

Review 3.  Medical regimens for abortion at 12 weeks and above: a systematic review and meta-analysis.

Authors:  Katherine Whitehouse; Ashley Brant; Marita Sporstol Fonhus; Antonella Lavelanet; Bela Ganatra
Journal:  Contracept X       Date:  2020-08-20

4.  Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill.

Authors:  Ruvani T Jayaweera; Heidi Moseson; Caitlin Gerdts
Journal:  Sex Reprod Health Matters       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.